Brief: Cantargia Receives Regulatory Approval For Phase I Trial For CAN10
10/08/2023 14:37
Aug 10 (Reuters) - Cantargia AB CANTA.ST :
* CANTARGIA RECEIVES REGULATORY APPROVAL TO START PHASE I
CLINICAL
TRIAL FOR CAN10
* UP TO 80 SUBJECTS MAY BE INCLUDED IN TRIAL, WHICH IS
EXPECTED TO
START IN SEPTEMBER 2023
Source text for Eikon: ID:nMFN7vPdkC
Further company coverage: CANTA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))